How does TMEM106B influence cognitive resilience independently of AD pathology burden?

OPEN

The abstract reports TMEM106B variants affect resilience independent of tau and amyloid pathology, creating a paradox where genetic factors provide protection through unknown pathways. This represents a novel mechanism of resilience that could be therapeutically exploited. Gap type: unexplained_observation Source paper: Cognitive resilience to Alzheimer's disease characterized by cell-type abundance. (None, None, PMID:39262221)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: How does TMEM106B influence cognitive resilience independently of AD pathology burden? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does TMEM106B influence cognitive resilience independently of AD pathology burden? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (15)

entities-ros→ADentities-atp7b-gene→ADentities-histone-methylation→ADTDP-43→ADTAU→AD

▸ Show 10 more

APOE→ADALZHEIMER DISEASE→TMEM106BMIR-146A→ADSOD1→ADAD→TAUSV2A→ADAPOE genotype→ADBnip3→ADTMEM106B→neurodegenerationtau N-terminal fragments→AD

biomarker for (1)

tau cleavage products→AD

causes (6)

AD→neurodegenerationAD→DEMENTIABETA_AMYLOID→ADPHOSPHORYLATED_TAU→ADAD→memory_loss

▸ Show 1 more

AD→IMMUNE_TOL

▸ Show 1 more

NAD+ augmentation→AD

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps

How does TMEM106B influence cognitive resilience independently of AD pathology burden?

Key Unanswered Questions

Key Researchers

Clinical Trials

Hypothesis Score Distribution

associated with (15)

biomarker for (1)

causes (6)

cross disease mechanism in (4)

data in (3)

depleted in (1)

modulates (1)

participates in (2)

prevents (1)

protective against (1)

provides data for (1)

regulates (3)

risk factor for (4)

targets (1)

therapeutic target for (6)